This page contains brief information about doxorubicin hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Doxorubicin hydrochloride is approved to be used alone or with other drugs to treat:
- Acute lymphoblastic leukemia (ALL).
- Acute myeloid leukemia (AML).
- Breast cancer. It is also used as adjuvant therapy for breast cancer that has spread to the lymph nodes after surgery.
- Gastric (stomach) cancer.
- Hodgkin lymphoma.
- Neuroblastoma.
- Non-Hodgkin lymphoma.
- Ovarian cancer.
- Small cell lung cancer.
- Soft tissue and bone sarcomas.
- Thyroid cancer.
- Transitional cell bladder cancer.
- Wilms tumor.
Doxorubicin hydrochloride is also being studied in the treatment of other types of cancer.
Doxorubicin hydrochloride is also available in a different form called doxorubicin hydrochloride liposome. For more information, see the Drug Information Summary for Doxorubicin Hydrochloride Liposome.
More About Doxorubicin Hydrochloride
Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.
MedlinePlus Information on Doxorubicin Hydrochloride – A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
